BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Wang M, Zhu Z, Ding C, Chen S, Wu H, Yang Y, Che F, Li Q, Li H. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy. Int J Nanomedicine 2021;16:3217-40. [PMID: 34007175 DOI: 10.2147/IJN.S302450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Reference Citation Analysis]
2 El Moukhtari SH, Garbayo E, Fernández-Teijeiro A, Rodríguez-Nogales C, Couvreur P, Blanco-Prieto MJ. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system. J Control Release 2022;348:553-71. [PMID: 35705114 DOI: 10.1016/j.jconrel.2022.06.010] [Reference Citation Analysis]
3 Guo Z, Zhao M, Liu Z. Molecularly imprinted and cladded nanoparticles for high-affinity recognition of structurally closed gangliosides. Mikrochim Acta 2022;189:289. [PMID: 35879493 DOI: 10.1007/s00604-022-05395-2] [Reference Citation Analysis]
4 Sabbih GO, Danquah MK. Neuroblastoma GD2 Expression and Computational Analysis of Aptamer-Based Bioaffinity Targeting. Int J Mol Sci 2021;22:9101. [PMID: 34445807 DOI: 10.3390/ijms22169101] [Reference Citation Analysis]